Efficacy of the benznidazole+posaconazole combination therapy in parasitemia reduction: An experimental murine model of acute chagas
Introduction: Benznidazole (BZL) and Nifurtimox (NFX) are the pharmacological treatment for acute phase Chagas Disease (CD); however, therapy resistance and residual mortality development remain important unresolved issues. Posaconazole (POS) has shown a trypanocidal effect in vivo and in vitro. Thu...
- Autores:
-
Echeverría L.E.
González C.I.
Hernandez J.C.M.
Díaz M.L.
Nieto Pico, Javier Eduardo
López-Romero L.A.
Rivera J.D.
Suárez E.U.
Ochoa S.A.G.
Rojas L.Z.
Morillo C.A.
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad Cooperativa de Colombia
- Repositorio:
- Repositorio UCC
- Idioma:
- OAI Identifier:
- oai:repository.ucc.edu.co:20.500.12494/42289
- Palabra clave:
- Wistar rats
Chagas Disease
Trypanocidal
Benznidazole and Posaconazole
- Rights
- closedAccess
- License
- http://purl.org/coar/access_right/c_14cb